Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06637774 · ClinicalTrials.gov registry record · NA
The Aspirometer: A Noninvasive Tool for Detecting Aspiration Aim 3
A NA study of Deglutition Disorders, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06637774: Completed NA study of Deglutition Disorders, sponsored by University of Pittsburgh.
NCT06637774 is a NA study of Deglutition Disorders that has completed, run by University of Pittsburgh. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06637774, a NA study of Deglutition Disorders, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This investigation evaluates the effectiveness of a device called the Aspirometer, which uses high resolution cervical auscultation (HRCA), in detecting when food or liquids enter the airway (aspiration) of the person swallowing, whether the person swallowing shows signs of aspiration (coughing) or not.
Primary Outcome
Patients will undergo the Yale Swallow Protocol Screening Test and videofluoroscopic swallow study (VFS) while being concurrently monitored by the Aspirometer. Blinded trained human judges will score the screening test per its protocol indicating pass or fail based on the test's manual. Participants then immediately undergo a videofluoroscopic swallowing study during the same visit. Judgments of their penetration-aspiration scale (PAS) scores on the will serve as the gold standard for whether ab
Conditions Studied
Interventions
- DEVICE Aspirometer
- DEVICE Videofluoroscopic X-ray
Study Locations (1)
Pennsylvania
- University of Pittsburgh Medical Center Oakland campus - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-09-30 |
| Est. Completion | 2023-05-31 |
| Phase | NA |
What the finished NCT06637774 record still lists
NCT06637774 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Deglutition Disorders appearing as the primary indexed condition, and to 2 interventions - of which Aspirometer is the first listed.
NCT06637774 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06637774 about?
NCT06637774 is a clinical study titled "The Aspirometer: A Noninvasive Tool for Detecting Aspiration Aim 3". This investigation evaluates the effectiveness of a device called the Aspirometer, which uses high resolution cervical auscultation (HRCA), in detecting when food or liquids enter the airway (aspiration) of the person swallowing, whether the person swallowing shows signs of aspiration (coughing) or ...
What is the current status of trial NCT06637774?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2022-09-30. Estimated completion is 2023-05-31.
What conditions does trial NCT06637774 study?
This clinical trial studies the following conditions: Deglutition Disorders.
What interventions are being tested in trial NCT06637774?
The interventions under investigation include: Aspirometer (DEVICE), Videofluoroscopic X-ray (DEVICE).
Who is sponsoring clinical trial NCT06637774?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06637774 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Deglutition Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06637774's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI